FeLV Fluorescent RT PCR Kit Test Feline Stomatitis Cat DNA Kit FIV

Fluorescent qPCR Cat Stomatitis Multiple Pathogens ( FHV / FCV / FeLV / FIV ) DNA detection kit

Intend for Use:

This kit is suitable for the specific detection of feline herpes virus (FHV), feline calicivirus (FCV), feline leukaemia virus (FeLV) and feline AIDS virus (FIV) in cat eye, nose and mouth secretions and EDTA whole blood samples.

Principle:

Under the action of high-efficiency reverse transcriptase, cDNA strands complementary to RNA template were synthesized with PRIMER as starting point and RNA template as template. Choose cat herpes virus, cat goblet virus, feline leukemia virus, HIV gene conservative design specific probe, the probe can with primer amplification area in the middle of a specific binding DNA template, in the process of PCR extension, the circumscribed Taq polymerase enzymes from the 5 'end of fluorescent groups on the probe will be cut down, make it free in the reaction system, In this way, the 3 '-end quenched group is separated, and the fluorescence is emitted, and the nucleic acid detection of feline herpes virus, feline calicivirus, feline leukaemia virus and feline AIDS virus is realized in the completely closed reaction system by fluorescence PCR instrument.

Component:

FHV/FCV PCR Reaction reagent:

Note: "+" means positive, "-" means negative
FeLV/FIV PCR PCR Reaction reagent:

Product performance index:

1. Accuracy

The positive reference material of testing enterprises were all positive.

2. Minimum detection limit: The detection limit of this kit is 10 copies/μL.

3. Precision: Coefficient of variation (CV,%) of intra-batch precision Ct value is ≤5%.

Bio key Health is a high-tech enterprise with integrating R&D, production and sales&marketing in Guangzhou. Since 2003. Bio Key was founded by the "Thousand Talents Program" entrepreneurial team and the overseas senior automation equipment development engineer team.

The company's core team has been in the field of IVD research and entrepreneurship for more than 10 years, and has mastered a wealth of molecular diagnostic POCT industrial application technology, SmartTRF immune detection technology, RT qPCR nucleic acid detection technology and independent research and development capabilities of instruments.

It has a number of independent core technologies in the fields of automation engineering, micro-precision manufacturing, immunofluorescence, nucleic acid detection and gene sequencing. Since its establishment, the company has applied for more than 60 patents and currently has 17 authorized patents. The company has two R&D centers for diagnostic reagents and instruments and equipment, totaling more than 500 square meters; it has established more than 2,000 square meters of GMP workshops and equipment production plants; it has SmartTRF new immune detection technology, nucleic acid detection technology (POCT) and three scientific services.